Pharmaceuticals, Biotechnology and Life Sciences
Intertrade Shipping AS har mandag 15. mars kjøpt 1.500.000 aksjer i Vistin Pharma ASA forNOK 23,60 pr. aksje. Intertrade Shipping AS eier etter kjøpet 12.575.000 aksjeri Vistin Pharma AS, tilsvarende 28,4 % av utestående aksjer i selskapet.Intertrade S…
Press Release 16 March 2021 Immunicum AB (publ) Announces Updated Executive Management Team After Business Combination Immunicum AB (publ; IMMU.ST) announced today the establishment of an updated executive management team following the initial int…
The cobas SARS-CoV-2 Variant Set 1 Test is designed to detect key spike mutations in virus variants associated with increased human-to-human transmissionAccurate detection and differentiation of SARS-CoV-2 mutations can help assess the spread of circul…
SUNFISH Part 2 study population includes broad range of ages and disease severities, representing a real-world spectrum of people living with Type 2 or 3 SMAEvrysdi is the first and only at home SMA treatment approved by the FDA, and has proven efficac…
MARSEILLE, France, March 16, 2021 (GLOBE NEWSWIRE) — Innate Pharma SA (Euronext Paris: IPH – ISIN: FR0010331421; Nasdaq: IPHA) (“Innate” or the “Company”), today announced that the Company will hold a conference call on Thursday, March 18, 2021 at 2…
Marseille, March 16, 2021 (GLOBE NEWSWIRE) — Innate Pharma SA (Euronext Paris: IPH – ISIN: FR0010331421; Nasdaq: IPHA) (“Innate” or the “Company”), today announced that the Company will hold a conference call on Thursday, March 18, 2021 at 2 p.m. CE…
TORONTO, March 15, 2021 (GLOBE NEWSWIRE) — We are advised by Avicanna Inc. that journalists and other readers should disregard the news release, “Avicanna to present at the Q1 Virtual Investor Summit” issued March 11, 2021, over GlobeNewswire.
Anchiano shareholders approve all resolutions at shareholder meeting The merged company is expected to receive approximate gross proceeds from the private financing of $45.5 million, which will be used to advance the Chemomab pipeline TEL-AVIV, Israe…
– Firdapse® Q4-20 Net Revenues of $31.0 Million, FY-20 Net Revenues of $119.1 Million – GAAP Net Income of $75.0 Million for Fiscal Year 2020 – $140.3 Million in Cash and Investments and No Funded Debt – Company to Host Quarterly Conference Call at …
Daix (France), March 15, 2021 – Inventiva (Euronext Paris and Nasdaq: IVA), a clinical-stage biopharmaceutical company focused on the development of oral small molecule therapies for the treatment of non-alcoholic steatohepatitis (NASH), mucopolysaccha…